The Ministry of Health on Wednesday recommended to continue using the AstraZeneca vaccine in vaccination campaigns, following a meeting on the issue of the National Advisory Pharmacovigilance Commission.
The Commission met on Wednesday to study and assess the side effects regarding coagulation disorders and thromboembolic events in people inoculated with AstraZeneca vaccine, the ministry said in a release.
The members of the Commission unanimously confirmed that the benefits of the AstraZeneca vaccine outweigh the risks and that there is no direct link between these side effects and the use of this vaccine.
The ministry of Health stresses that it is regularly monitoring the safety of the coronavirus vaccines in the Kingdom by monitoring and analyzing side effects cases, scientific evidence and available data on this subject at the national and international level, in coordination with health and regulatory authorities.
The ministry urges all citizens and health practitioners to inform the National Center of Pharmacovigilance through the following website of the side effects of COVID-19 vaccines: https://www.liqahcorona.ma/fr/evenements_indesirables
No deaths have been recorded among AstraZeneca vaccine recipients have been recorded so far as a result of complications related to side effects of the vaccine, according to the same source.
“Protecting the health of all citizens is one of its priorities and no effort will be spared. Any new data regarding vaccines and their safety will be announced through official channels,” the statement concluded.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.